Status:
COMPLETED
Comparison of the Efficacy of Acupressure P6 Point, Dexamethasone and Ondansetron Versus Palonosetron Monotherapy for Preventing Postoperative Nausea and Vomiting in Laparoscopic Surgery
Lead Sponsor:
Mohd Zulfakar Mazlan, MBBS
Conditions:
Palonosetron
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Postoperative nausea and vomiting (PONV) is defined as nausea and/or vomiting occurring within 24 hours after surgery, it commonly affects 20-30% patients but as high as 70-80% patients who are deemed...
Detailed Description
This study is designed to compare the efficacy of palonosetron monotherapy versus combination of acupressure P6 point with dexamethasone and ondansetron in preventing PONV. It has been proven that pal...
Eligibility Criteria
Inclusion
- ASA I or II female patients aged 18 - 65 years old in view female patients are at higher risk of postoperative nausea and vomiting.
- Patients undergoing laparoscopic surgery.
- High risk for PONV (APFEL score 3-4).
Exclusion
- Patients with known allergic to dexamethasone, ondansetron and wristband.
- Patients who take anti-emetic, emetogenic drugs and glucocorticoids within 24 hours before surgery.
- Patients with upper limb disability which affect the application of wristband.
- Obese patients with BMI \> 35 in view acupressure P6 wristband might be too tight to fit patient's wrist which might affect the correct placement of pressure point.
- Pre-existing vertigo
Key Trial Info
Start Date :
July 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2021
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04461093
Start Date
July 6 2020
End Date
November 1 2021
Last Update
May 1 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Mohd Zulfakar Mazlan, MBBS
Kota Bharu, Kelantan, Malaysia, 16150
2
Mohd Zulfakar Mazlan
Kota Bharu, Kelantan, Malaysia, 16150